These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2085148)

  • 21. D-penicillamine-induced angiopathy in rats. Changes in aortic collagen, glycosaminoglycans, DNA and RNA in rats treated with D-penicillamine.
    Junker P; Helin G; Jensen BA; Oxlund H; Lorenzen I
    Atherosclerosis; 1982 Oct; 45(1):17-31. PubMed ID: 6186262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics of D-penicillamine.
    Netter P; Bannwarth B; Péré P; Nicolas A
    Clin Pharmacokinet; 1987 Nov; 13(5):317-33. PubMed ID: 3319347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.
    Nagata N; Hurtenbach U; Gleichmann E
    J Immunol; 1986 Jan; 136(1):136-42. PubMed ID: 2415613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of dithiobiuret toxicity in rats.
    Williams KD; Lopachin RM; Atchison WD; Peterson RE
    Neurotoxicology; 1986; 7(1):33-49. PubMed ID: 3012425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic studies on 14 C-labelled penicillamine].
    Planas-Bohne F
    Arzneimittelforschung; 1972 Sep; 22(9):1426-33. PubMed ID: 4678603
    [No Abstract]   [Full Text] [Related]  

  • 29. D-penicillamine prevents ram sperm agglutination by reducing the disulphide bonds of a copper-binding sperm protein.
    Leahy T; Rickard JP; Aitken RJ; de Graaf SP
    Reproduction; 2016 May; 151(5):491-500. PubMed ID: 26860122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability and pharmacokinetics of D-penicillamine.
    Kukovetz WR; Beubler E; Kreuzig F; Moritz AJ; Nirnberger G; Werner-Breitenecker L
    J Rheumatol; 1983 Feb; 10(1):90-4. PubMed ID: 6842492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the ability of d-penicillamine to protect rats against the neurotoxicity induced by zinc pyridinethione, acrylamide, 2,5-hexanedione and p-bromophenylacetylurea.
    LoPachin RM; Weiler MS; Williams KD; Peterson RE
    Neurotoxicology; 1984; 5(2):37-41. PubMed ID: 6542189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An outline of D-penicillamine metabolism.
    Perrett D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):61-4. PubMed ID: 122676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma D-penicillamine redox state evaluation by capillary electrophoresis with laser-induced fluorescence.
    Zinellu A; Carru C; Sotgia S; Deiana L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):299-304. PubMed ID: 15063339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillamine: pharmacokinetics and differential effects on zinc and copper status in chicks.
    Lü JX; Combs GF
    J Nutr; 1992 Feb; 122(2):355-62. PubMed ID: 1732476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1H-nuclear magnetic resonance study of the oxidation/reduction chemistry of penicillamine in intact human erythrocytes.
    Millis KK; Rabenstein DL
    Biochim Biophys Acta; 1990 Oct; 1055(1):10-8. PubMed ID: 2171674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of aromatic disulphides. III. In vivo haemolytic activity of aromatic disulphides.
    Munday R; Manns E
    J Appl Toxicol; 1985 Dec; 5(6):414-7. PubMed ID: 4078223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compartmental study on the pharmacokinetics of D-penicillamine.
    Polig E; Planas-Bohne F
    Biophysik; 1973; 10(4):321-36. PubMed ID: 4791126
    [No Abstract]   [Full Text] [Related]  

  • 38. High performance liquid chromatography analysis of D-penicillamine by derivatization with N-(1-pyrenyl)maleimide (NPM).
    Yusof M; Neal R; Aykin N; Ercal N
    Biomed Chromatogr; 2000 Dec; 14(8):535-40. PubMed ID: 11113937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence turn-on assay for detection of serum D-penicillamine based on papain@AuNCs-Cu
    Chen Y; Qiao J; Liu Q; Zhang M; Qi L
    Anal Chim Acta; 2018 Oct; 1026():133-139. PubMed ID: 29852989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversibility of D-penicillamine induced collagen alterations in rat skin and granulation tissue.
    Junker P; Lorenzen I
    Biochem Pharmacol; 1983 Jun; 32(11):1753-7. PubMed ID: 6870917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.